Henry Schein (HSIC) said Wednesday that it has signed a deal to acquire medical products supplier Acentus.
Financial terms of the acquisition were not disclosed.
Henry Schein said it expects to complete the deal in Q1 and estimates the acquisition to be neutral to 2024 non-GAAP earnings per share, but accretive thereafter.